 
                    
                Noile-Immune Biotech Inc.
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
4893 | T
Overview
Corporate Details
- ISIN(s):
- JP3759560000
- LEI:
- Country:
- Japan
- Address:
- 港区芝大門二丁目12番10号
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Noile-Immune Biotech Inc. is a clinical-stage biotechnology company focused on the development and commercialization of novel cancer immunotherapies. The company specializes in CAR-T cell therapy aimed at treating solid tumors, a significant challenge in oncology. Its core is the proprietary PRIME (Proliferation-Inducing and Migration-Enhancing) technology, a next-generation platform designed to augment the efficacy of CAR-T cells. Noile-Immune advances its therapeutic pipeline through in-house research and strategic partnerships with academic and corporate entities, with the mission to create transformative treatments for cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-08 09:15 | Report Publication Announcement 確認書 | Japanese | 8.1 KB | ||
| 2025-08-08 09:14 | Interim Report 半期報告書-第11期(2025/01/01-2025/12/31) | Japanese | 143.9 KB | ||
| 2025-04-01 09:11 | Post-Annual General Meeting Information 臨時報告書 | Japanese | 23.5 KB | ||
| 2025-03-28 05:44 | Registration Form 確認書 | Japanese | 8.2 KB | ||
| 2025-03-28 05:43 | Governance Information 内部統制報告書-第10期(2024/01/01-2024/12/31) | Japanese | 21.2 KB | ||
| 2025-03-28 05:42 | Annual Report 有価証券報告書-第10期(2024/01/01-2024/12/31) | Japanese | 4.1 MB | ||
| 2024-10-15 05:07 | Report Publication Announcement 訂正確認書 | Japanese | 8.2 KB | ||
| 2024-10-15 05:06 | Interim Report 訂正半期報告書-第10期(2024/01/01-2024/12/31) | Japanese | 124.4 KB | ||
| 2024-08-13 05:02 | Interim Report 半期報告書-第10期(2024/01/01-2024/12/31) | Japanese | 150.3 KB | ||
| 2024-08-13 05:00 | Report Publication Announcement 確認書 | Japanese | 8.1 KB | ||
| 2024-05-14 10:07 | Report Publication Announcement 確認書 | Japanese | 8.1 KB | ||
| 2024-05-14 10:05 | Quarterly Report 四半期報告書-第10期第1四半期(2024/01/01-2024/03/31) | Japanese | 117.7 KB | ||
| 2024-04-02 06:49 | Regulatory News Service 臨時報告書 | Japanese | 22.2 KB | ||
| 2024-03-29 06:19 | Registration Form 確認書 | Japanese | 8.2 KB | ||
| 2024-03-29 06:18 | Governance Information 内部統制報告書-第9期(2023/01/01-2023/12/31) | Japanese | 21.2 KB | 
Automate Your Workflow. Get a real-time feed of all Noile-Immune Biotech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Noile-Immune Biotech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Noile-Immune Biotech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                    